Metronidazole Extended Release Tablets USP 600mg – Pretogyl Tablets

PRETOGYL Tablets – Trusted Antimicrobial Protection, Extended & Effective

Pretogyl Tablets – Metronidazole Extended Release Tablets USP is a nitroimidazole-class antimicrobial agent with both antiprotozoal and antibacterial effects. It disrupts DNA synthesis in anaerobic organisms and protozoa, leading to cell death. The sustained-release (SR) formulation ensures prolonged activity, reducing the need for frequent dosing, particularly beneficial in chronic infections such as amoebiasis or bacterial vaginosis.

Key Benefits of Metronidazole Extended Release Tablets – PRETOGYL Tablets
✅ Sustained-Release for Better Compliance – Once or twice daily dosing maintains consistent therapeutic levels, enhancing patient adherence in chronic infections.
✅ Effective against Anaerobic & Antiprotozoal both – Effective against Entamoeba histolytica, Giardia lamblia, Trichomonas vaginalis, and anaerobic bacteria like Bacteroides.
✅ Reduces Recurrence & Resistance Risk – Extended exposure reduces bacterial load and helps prevent treatment failure or resistance.

Recommended By Specialists:
👨‍⚕️ General Physicians: For anaerobic bacterial infections, pelvic inflammatory disease, or dental infections.
👨‍⚕️ Gastroenterologists: For treating Clostridium difficile infections, Helicobacter pylori regimens, or protozoal infections like amoebiasis and giardiasis.
👩‍⚕️ Gynecologists: For bacterial vaginosis, pelvic infections, and postoperative prophylaxis in gynecologic surgeries.

INDICATIONS:
✅ Amoebiasis (Intestinal & Hepatic)
✅ Giardiasis
✅ Trichomoniasis
✅ Anaerobic Bacterial Infections
✅ Bacterial Vaginosis
✅ Pelvic Inflammatory Disease
✅ Surgical Prophylaxis in Colorectal Procedures